“Atorvastatin Suppresses Lipopolysaccharideinduced Inflammation in Human Coronary Artery Endothelial Cells”. Brazilian Journal of Pharmaceutical Sciences, vol. 58, Apr. 2022, https://doi.org/10.1590/s2175-979020200001181092.